A B S T R A C T
Background. Kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) are promising biomarkers for monitoring delayed graft function (DGF) after kidney transplantation. Here we investigated localization and distribution of KIM-1 and NGAL staining in renal allograft biopsies and studied their association with histological features, functional DGF (fDGF) and the tubular function slope (TFS), a functioning proximal tubular epithelial cell (PTEC) marker. Methods. Day 10 protocol biopsies of 64 donation after circulatory death recipients were stained for KIM-1 and NGAL and the positive area was quantified using ImageJ software. Biopsies were scored according to Banff and acute tubular necrosis (ATN) criteria. A 99m technetium-mercaptoacetyltriglycine ( 99m Tc-MAG3)-renography was performed to calculate TFS. Results. KIM-1 staining was located on the brush border of tubular epithelial cells (TECs) and correlated with denudation, while NGAL was present more focally in a cytoplasmic distribution. KIM-1 and NGAL staining were not correlated and no colocalization was observed. Quantitative stainings were not associated with fDGF, but KIM-1 tended to be higher in patients with prolonged fDGF (!21 days; P ¼ 0.062). No correlation was observed between the quantitative tissue stainings and urinary KIM-1 or NGAL. Quantitative KIM-1 staining was inversely correlated with the TFS (Spearman's q ¼ À0.53; P < 0.001), whereas NGAL was not. The latter finding might be because cortical NGAL staining is dependent on filtration and subsequent reabsorption by functioning PTECs. Staining of NGAL was indeed restricted to PTECs, as shown by co-localization with a PTEC-specific lectin. Conclusions. KIM-1 and NGAL staining showed different localization and distribution. Quantitative KIM-1 staining was inversely correlated with functioning PTECs.
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I N T R O D U C T I O N
In the past decade, the reported incidence of delayed graft function (DGF) after kidney transplantation has increased, contemporaneous with the more frequent use of extended criteria donors, including donation after circulatory death (DCD) [1] . DGF is associated with an increased number of kidney biopsies performed early after transplantation, prolonged hospitalization and higher transplantation costs [2] . The impact of DGF on long-term outcomes, however, remains controversial. Some studies reported that DGF negatively affected long-term outcome parameters [2, 3] , whereas others found no such relationship [4, 5] . The principal cause of DGF is ischemia-reperfusion injury (IRI), which results in extensive loss of (functional) tubular epithelial cells (TECs). Measuring the severity of tubular cell injury would help to predict the risk of DGF and may also contribute to the development of new strategies to prevent DGF.
Both kidney injury marker 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) have been proposed as biomarkers to detect tubular cell injury in acute kidney injury (AKI) but also in the transplant setting. A recent meta-analysis showed that both KIM-1 and NGAL in urine could predict AKI 24 h after cardiac surgery, with an area under the receiver operating characteristic curve (AUC) of 0.72 [6] . In kidney transplantation, a recent systematic review showed that NGAL measurements in urine and serum overall had excellent performance for the prediction of DGF, with an AUC of 0.87 [7] . Studies investigating the performance of KIM-1 in the prediction of DGF have reported less convincing results, with AUCs of 0.50 and 0.62 [8, 9] . The only study that found an AUC of 0.99 [10] investigated only nine patients with DGF. The translation of both biomarkers into the clinic has not (yet) been achieved. More detailed evaluation of the expression and localization of these biomarkers in renal tissue may help in the interpretation of urine and serum values, as well as increase insights in pathophysiology.
KIM-1 and NGAL expression in tissue has been investigated in several studies. Normal kidneys display only minimal or absent KIM-1 and NGAL expression, whereas the expression of both biomarkers significantly increased in cases of acute tubular necrosis (ATN) [11, 12] . In renal allograft biopsies, it was suggested that KIM-1 staining was a more sensitive marker than histology by light microscopy for detecting early tubular injury, as 28% of cases showed focal KIM-1 expression without any sign of tubular injury in conventional histology [13] . This study also showed that KIM-1 expression was present in all (n ¼ 25) biopsies with acute tubular injury and 92% (11/12) of the biopsies with acute cellular rejection. An increased staining intensity in kidneys with an acute rejection episode has also been reported for NGAL; however, details were not provided [14] .
To the best of our knowledge, only two previous studies investigated KIM-1 and NGAL expression in relation to DGF. The first study investigated KIM-1 RNA and protein expression in pre-perfusion biopsies of 30 living and 85 deceased-donor kidneys and correlated the results with histologic and clinical outcomes [15] . The level of KIM-1 expression before reperfusion correlated with renal function at the time of kidney procurement and directly with the degree of fibrosis (scored by the positive area in periodic acid-Schiff subtracted from trichrome). However, KIM-1 expression was not correlated with the occurrence of DGF [15] . This is in contrast to NGAL staining, which was found to correlate significantly with DGF in 25 renal allograft biopsies taken 1 h after reperfusion [16] .
Here we investigated in a cohort of DCD kidney transplant recipients the presence, localization and distribution of KIM-1 and NGAL in protocol renal allograft biopsies obtained 10 days after transplantation. We examined their association with histological characteristics, as well as the presence and duration of functional DGF (fDGF) in combination with the tubular function slope (TFS) as a quantitative marker of functional proximal TECs (PTECs). In addition, quantitative KIM-1 and NGAL staining were correlated with the corresponding urinary KIM-1 and NGAL values. Finally, in order to obtain more detailed insights in the kinetics, localization and distribution, both KIM-1 and NGAL were studied at several time points in a rat model of IRI.
M A T E R I A L S A N D M E T H O D S

Patient population
In all, 92 DCD recipients participated in a randomized controlled trial that was conducted from 2005 to 2009 at the Leiden University Medical Center [17] . DCD donors (Maastricht III) were allocated according to the allocation algorithm and matching criteria of Eurotransplant. The study was approved by the Ethical Committee of the Leiden University Medical Center and written informed consent was obtained from the patient before enrolment. By protocol, all patients underwent a renal biopsy 10 days after transplantation. For the current study, adequate samples from Day 10 protocol biopsies were available of 64 DCD recipients. Missing biopsies were not performed because of withdrawal of consent (n ¼ 7), primary nonfunction (n ¼ 2), not enough tissue available (n ¼ 12) or technical failure of the staining on frozen sections (n ¼ 7). All biopsies were scored by an experienced pathologist according the semi-quantitative ATN score as described by Goujon et al. [18] and the Banff 2009 working classification for renal allograft pathology [19] . Moreover, cryosections were used for immunohistochemistry.
The immunosuppressive regimen was similar in all patients, consisting of induction therapy with anti-CD25 antibody (daclizumab, Roche Pharmaceuticals; intravenous bolus 100 mg preoperatively and on Day 10) and maintenance with cyclosporine A microemulsion (Neoral, Novartis), mycophenolate mofetil (Roche) and steroids.
DGF was defined according to the fDGF definition [4] . In order to monitor fDGF, a standardized 99m technetium-mercaptoacetyltriglycine ( 99m Tc-MAG3) renography was performed 10 days after transplantation. Subsequently a TFS was determined to assess tubular uptake of 99m Tc-MAG3 [20] . This TFS value may be used as a marker to assess functional renal PTECs [20] .
Furthermore, urinary samples were collected for KIM-1 and NGAL measurements 10 days after transplantation following the same standard operating procedure throughout the whole study. This included an immediate mild centrifugation of urine for 10 min at 1000 g, and splitting into aliquots of 1 mL that were immediately stored at À80 C until analysis. KIM-1 was measured using a human KIM-1 DuoSet enzyme-linked immunosorbent assay (ELISA: R&D Systems, Abingdon, UK) and NGAL using a human lipocalin-2/NGAL DuoSet ELISA (R&D Systems). Urine was diluted 1:10 and 1:100 for KIM-1 and 1:100 and 1:1000 for NGAL. Samples were processed according to the manufacturer's instructions.
Immunohistochemistry and immunofluorescence staining in human kidney biopsies
Immunohistochemical staining was performed on frozen sections of 3 lm. Kidney sections were air dried and fixed with acetone. Slides were incubated overnight with mouse immunoglobulin 1 (IgG 1 ) anti-NGAL monoclonal antibody (mAb; Hycult Biotech, Uden, The Netherlands) or mouse immunoglobulin 2b (IgG 2b ) anti-recombinant KIM mAb (R&D Systems), both followed by horseradish peroxidase (HRP)-labelled goat anti-mouse (Dako, Heverlee, Belgium). The staining was visualized using Nova RED (Vector Labs, Peterborough, UK) and counterstained with hematoxylin (Merck, Darmstadt, Germany). The specificity of the different staining procedures was shown by negative staining when using isotype-matched control antibodies. KIM-1 and NGAL staining was not observed in control pre-transplant human biopsies. The positive area in each image (expressed in pixels) was quantified in a blinded manner using ImageJ software.
A double staining was performed to investigate colocalization of KIM-1 and NGAL. Kidney sections were air dried, fixed with acetone and incubated with the same primary antibodies as described above. The fluorescent secondary antibodies used were Alexa Fluor 488 goat anti-mouse IgG 2b and
For the double staining with the fluorescent lectins and NGAL, the same primary and secondary antibodies were used as in the double staining. Accordingly, slides were incubated with the proximal tubular marker Phaseolus vulgaris erythroagglutinin (PHA-E; Vector Labs) or with the distal tubular marker Dolichos biflorus agglutinin (DBA; Vector Labs) [21] .
Animals and surgical procedures
In a previously established IRI model, unilateral ischemia was induced and quantitative KIM-1 and NGAL staining was investigated. Unilateral ischemia was induced in 8-week-old male Lewis rats by clamping the left renal pedicle for 45 min [22] . In total, six rats were included. The Animal Care and Use Committee of the Leiden University Medical Center approved all experiments. During clamping of the left renal pedicle, the contralateral kidney was removed. The sham rats also underwent surgery, with removal of the contralateral kidney, however, without clamping of the left kidney. Rats were sacrificed at 2, 5, 24, 48 and 72 h and 1 week after reperfusion. The kidneys were removed and snap-frozen and were used for immunohistochemical staining.
Immunohistochemistry and immunofluorescence staining in rat kidneys
In rats, immunohistochemical staining was performed on frozen kidney sections. Slides were incubated overnight with mouse anti-rat NGAL mAb (Abcam, Cambridge, UK) or goat anti-rat KIM polyclonal antibody (pAb; R&D Systems) followed by HRP-labelled goat anti-mouse (Jackson Immunoresearch, Suffolk, UK) or HRP-labelled rat anti-goat (Dako), respectively. Subsequently, slides were incubated with tyramide-fluorescein isothiocyanate (Tyr-FITC; Sigma-Aldrich, Zwijndrecht, The Netherlands) and with HRP-labelled rabbit anti-FITC antibody (Abcam). The staining was visualized using Nova Red (Vector Labs) and counterstained with hematoxylin (Merck). KIM-1 and NGAL staining was not observed in the contralateral nonischemic rat kidney. Quantification was performed in a blinded manner using ImageJ software and the positive area was calculated.
To visualize co-expression of NGAL and KIM-1, a fluorescent double staining was performed. Slides were incubated overnight with mouse anti-rat NGAL mAb (Abcam) or goat anti-rat KIM pAb (R&D Systems), followed by HRP-labelled rat anti-mouse kappa antibody (Invitrogen) and alexa-488-labelled donkey antigoat antibody (Invitrogen) for NGAL and KIM-1, respectively. The staining was visualized using tyramide-labelled with tetramethylrhodamine-5-(and 6)-isothiocyanate (SigmaAldrich). Nuclei were stained using Hoechst (Molecular Probes, Leiden, The Netherlands).
For double staining with the fluorescent lectins and NGAL, the HRP-labelled rat anti-mouse kappa antibody was replaced by HRP-labelled goat anti-mouse antibody (Jackson Immunoresearch). Subsequently slides were incubated for 1 h with either PHA-E (Vector Labs) or DBA (Vector Labs) [21] .
Statistical analysis
The positive area percentage of KIM-1 and NGAL staining are reported as medians and interquartile ranges (IQRs) and baseline characteristics of the recipients as mean 6 SD, unless specified otherwise. Statistical comparisons were performed using an unpaired t-test or chi-square for parametric data and a Mann-Whitney U for nonparametric data, whichever was appropriate. The Spearman rank-order correlation test was utilized to determine correlations between quantitative KIM-1 and NGAL staining, the TFS and urinary values. A P-value < 0.05 was considered statistically significant. All analyses were performed using SPSS version 23.0 (IBM, Armonk, NY, USA) and GraphPad Prism version 7.0 (GraphPad Software, La Jolla, CA, USA).
R E S U L T S
General description of the biopsies
The Day 10 protocol biopsies of 64 DCD kidney transplant recipients were scored according to the Banff criteria [19] and the ATN score (Table 1 ) [18] . Almost all biopsies showed signs of ATN, most frequently cytoplasmic vacuolization and casts (both in 92.2% of biopsies), and to a lesser extent tubular dilatation (14.1%), denudation (20.3%) and regeneration (40.6%). Scarring lesions were also frequently observed; interstitial fibrosis and tubular atrophy (IF/TA) in 32.8% (Grade 1 and 2 in 14.1%, Grade 3 in 1.6% and Grade 4 in 3.1%), arterial fibrosis in 54.7%, hyalinosis in 37.5% and sclerosed glomeruli in 34.4%. Furthermore, interstitial inflammation was seen in 56.3% of the cases.
General description of KIM-1 and NGAL staining
Biopsies stained for both KIM-1 and NGAL were quantified using ImageJ software [23] . In Figure 1 , two biopsies, both stained for KIM-1 and NGAL, are presented as representative examples. In general, KIM-1-positive staining was seen at the brush border of the tubular epithelium, whereas the glomeruli were negative ( Figure 1A and 1B) . The median positive area percentage of the KIM-1 staining was 6.9% (range 0.9-19.9; Figure 1E ). NGAL was more focally present and appeared to be located in the cytoplasm of the TECs (Figure 1C and 1D) . The median positive area percentage of the NGAL staining was 3.0% (range 0.6-23.2; Figure 1E ). Remarkably, in patients with high KIM-1 staining, low NGAL staining was seen and vice versa, as illustrated by staining of the same part of a single biopsy ( Figure  1A and 1C; Figure 1B and 1D) . Thus, KIM-1 and NGAL staining were not significantly correlated (Spearman's q ¼ À0.23, P ¼ 0.067; Figure 1F ).
Subsequently, double staining with KIM-1 and NGAL was performed (Figure 2A ). This double staining showed no colocalization, indicating that both biomarkers indeed stain different parts of the kidney. In addition, it was assessed whether KIM-1 and NGAL staining were associated with specific histological features (Supplementary data, Table S1 ). Of all biopsy characteristics, NGAL was only associated with the presence of sclerosed glomeruli, with significantly lower 
KIM-1 staining, on the other hand, was only associated with denudation, with significantly higher KIM-1 staining in biopsies with denudation present (median of 10.8 versus 7.5% for biopsies with and without denudation; P ¼ 0.046; Figure 2B ). The latter finding was confirmed by the positive staining for KIM-1 in the thin line of cells that appear as dedifferentiated TECs [24] , as shown in Figure 2C . The cellular identity of KIM-1 positivity was better visualized by immunofluorescent staining, where nuclei were identified by Hoechst double staining (arrows, Figure 2D ). This strongly suggests that KIM-1 is expressed on dedifferentiated TECs.
Quantitative KIM-1 and NGAL staining were not associated with fDGF
Of the 64 DCD recipients, 15 patients were classified as primary function (functioning graft 7 days) and 49 patients as fDGF (functioning graft >7 days). The patients classified as fDGF were subsequently divided based on the duration of fDGF; 32 patients had 'limited' fDGF (functioning graft 8-20 days) and 17 patients had 'prolonged' fDGF (functioning graft >20 days). Donor, recipient and transplant characteristics were compared between patients with and without fDGF and between patients with limited and prolonged fDGF ( Table 2) . Donors of patients with fDGF were older in age, died more frequently of cerebrovascular accident (CVA) and had a higher number of HLA class I mismatches compared with patients without fDGF. Furthermore, patients in the prolonged fDGF group were more frequently male as compared with patients with limited fDGF. Several histological characteristics were also different; biopsies of patients with fDGF showed more frequently arteriolar hyalinosis and denudation compared with the patients without fDGF (P ¼ 0.005 and P ¼ 0.025, respectively) and interstitial inflammation and IF/TA were more frequently present in patients with prolonged fDGF (P ¼ 0.027 and P < 0.001, respectively; Supplementary data, Table S2 ).
Subsequently, quantitative KIM-1 and NGAL staining were compared with the presence and duration of fDGF. Both tissue stainings were not significantly different for patients with and those without fDGF, with a median of 7.7 versus 4.5% for KIM-1 (P ¼ 0.090) and 2.7 versus 4.7% for NGAL (P ¼ 0.122), respectively ( Figure 3A and 3B) . When the groups were compared based on the duration of fDGF, there was also no difference in quantitative NGAL staining (P ¼ 0.219; Figure 3D ). However, quantitative KIM-1 staining tended to be higher in patients with prolonged fDGF compared with patients with limited fDGF (median of 11.3 and 6.9%, respectively; P ¼ 0.062; Figure 3C ). This tendency of an increased KIM-1 staining with fDGF and prolonged fDGF might be related to the more frequent presence of denuded tubule epithelium.
TFS was significantly associated with KIM-1 staining
A standardized 99m
Tc-MAG3 renography was performed for all patients 10 days after transplantation and the TFS was calculated [20] . The TFS indicates tubular uptake of 99m Tc-MAG3 via the organic anion transporter and thus serves as a marker of Previously it was shown that TFS is strongly correlated with fDGF [20] . In the current study, Day 10 TFS values were also associated with fDGF, with a mean of 2.2 6 1.3 versus 1.3 6 1.0 for patients with and without fDGF, respectively (P ¼ 0.006; Table 2 ). As described above, KIM-1 and NGAL are both tubular injury markers, but their expression and distribution suggest a different role and function of both molecules. Therefore it was investigated whether KIM-1 or Figure 4A ). When a dichotomous variable was created of the TFS, this resulted in a significantly higher KIM-1 positive area for patients with a TFS 1.0 as compared with patients with a TFS >1.0 (P ¼ 0.001; Figure 4C ). This finding suggests that injury of the PTECs results in increased KIM-1 expression and diminished tubular uptake of 99m Tc-MAG3. Only a weak correlation was seen between TFS and quantitative NGAL staining (Spearman's q ¼ 0.24, P ¼ 0.055; Figure  4B) . Interestingly, the quantitative staining was significantly lower in patients with TFS 1.0 compared with patients with a TFS >1.0 (median of 1.6 and 4.1, respectively; P ¼ 0.022; Figure  4D ). We hypothesized that this was related to the physiology of NGAL, since NGAL staining is dependent on filtration and subsequent reabsorption by PTECs [25] . Both filtration and reabsorption may be more or perhaps impaired longer in donor kidneys with fibrosis. Indeed, in the group of patients with a TFS 1.0, IF/TA was more frequently observed as compared with patients with a TFS >1.0 (P ¼ 0.003; data not shown). Of note, two patients in the TFS 1.0 group had remarkably high NGAL staining. Both patients had a urinary tract infection at the time of the biopsy, which might explain the discrepant high quantitative NGAL staining. Double staining with the lectins PHA-E ( Figure 4E ) and DBA ( Figure 4F ), specific for proximal and distal tubular cells, respectively, confirmed that NGAL colocalized with PHA-E and not with DBA, indicating that the staining was present in the PTECs.
Quantitative KIM-1 and NGAL staining were not correlated with KIM-1 and NGAL concentrations in urine As mentioned in the introduction, several studies have shown that urinary KIM-1 and NGAL values are associated with DGF [7, 10] . In the current study, the concentration of KIM-1 and NGAL in urine at Day 10 was also significantly higher for patients with fDGF as compared with those without fDGF (P ¼ 0.025 for KIM-1 and P < 0.001 for NGAL). Subsequently we investigated whether quantitative KIM-1 and NGAL staining were correlated with the corresponding concentrations in urinary samples. However, both quantitative tissue stainings showed no correlation with urinary values (Spearman's q ¼ À0.15, P ¼ 0.910 for KIM-1 and Spearman's q ¼ À0.19, P ¼ 0.149 for NGAL; Supplementary data, Figure S1 ).
KIM-1 and NGAL staining was present in different parts of the rat kidney
In order to obtain more detailed insights in kinetics and localization, KIM-1 and NGAL staining were examined in a rat model of IRI. Rats were sacrificed at different time points after IRI so exact localization and distribution of both KIM-1 and NGAL staining could be analyzed over time. Interestingly, KIM-1 staining was predominantly located in the corticomedullary region, while NGAL staining was mainly present in the medulla and to a lesser extent in the cortical region ( Figure 5A and 5B). Both quantitative KIM-1 and NGAL staining increased from 24 h onwards ( Figure 5B ). The peak staining of NGAL was reached at 48 h, Figure 5D ). Moreover, double staining with the lectins PHA-E and DBA was comparable, with co-localization of NGAL with PHA-E ( Figure 5E ) and not with DBA (data not shown). This indicates that NGAL expression in the rats is similar to that of humans.
D I S C U S S I O N
The current study provides insights in the localization and distribution of KIM-1 and NGAL staining in Day 10 protocol renal biopsies of DCD kidney transplant recipients. We demonstrated that KIM-1 and NGAL were localized in different parts of the kidney, with KIM-1 on the brush border of TECs and correlating with the presence of denudation, whereas NGAL was found more focally in a cytoplasmic pattern. However, both quantitative KIM-1 and NGAL staining were not associated with the presence and duration of fDGF. KIM-1 tended to be higher in the subgroup of patients with prolonged fDGF. Furthermore, KIM-1 staining significantly correlated with TFS, a quantitative marker of functioning PTECs, while this was not the case with NGAL. The latter might be related to the fact that fibrotic kidneys were not (yet) able to filter and subsequently reabsorb NGAL by the PTECs. Co-localization with the lectin PHA-E indicated that NGAL staining was indeed restricted to the PTECs. In a rat model of IRI, we confirmed that KIM-1 and NGAL were localized in different parts of the kidney, in the corticomedullary region and cortex/ medulla, respectively, and that NGAL again localized in the PTECs. To the best of our knowledge, this is the first study comparing KIM-1 and NGAL staining in the same biopsies. We showed that KIM-1 and NGAL had a different localization and distribution pattern, suggesting a different role and function of both molecules in epithelial cell biology.
KIM-1 is a type 1 cell membrane glycoprotein that has been proposed to play an important role in kidney recovery and tubular regeneration by enhancing the clearance of apoptotic cells [26] . In rats, it has been shown that KIM-1 staining is absent in normal renal tissue and dramatically increased after ischemic injury [27] . In humans, KIM-1 expression is located on dedifferentiated PTECs and is upregulated in various renal diseases, including in patients with ATN [11, 13, 28] . In our cohort of DCD kidney transplant recipients, we confirmed KIM-1 staining was present on dedifferentiated TECs and showed that quantitative KIM-1 staining was associated with the presence of denudation.
NGAL, on the other hand, is a member of the lipocalin family and primarily produced in the thick ascending loop of Henle and the collecting duct. It is released in circulation and subsequently filtered by the glomerulus and reabsorbed by proximal tubules [12, 25, 29] . Ischemic injury resulted in increased NGAL synthesis in the distal nephron, but also impaired reabsorption by PTECs [12, 25, 30] . While healthy human kidney tissue showed weak staining in the distal tubular cells and collecting duct cells and negative staining in the proximal tubules, after ischemic injury a strong increase in staining intensity in PTECs was observed [12] . In accordance, in our rat IRI model, we found increased quantitative NGAL staining in the renal cortex, but also in the medulla. However, we could not identify positive NGAL staining in the distal tubular segments.
The different localization of KIM-1 and NGAL in rat kidneys (corticomedullary versus cortex and medulla) might explain the observed contrast in human biopsy specimens, with either high KIM-1 staining or high NGAL staining. Given the fact that the corticomedullary region is most susceptible to ischemic injury, we would expect to find an association between quantitative KIM-1 staining and fDGF. However, the association between fDGF and KIM-1 staining was not significant, although a clear trend towards higher quantitative staining was observed in the subgroup of patients who experienced a prolonged duration of fDGF. A previous study investigating KIM-1 expression in 115 renal allograft biopsies also did not observe a significant correlation between KIM-1 expression and DGF [15] . The preperfusion biopsies they used in their study may not be directly compared to our Day 10 protocol biopsies. In contrast with the results from our study, a significant correlation between NGAL staining and DGF has been described in biopsies obtained 1 h after reperfusion [16] . This was a small study, however, including only 12 kidney biopsies of living donors and 13 of cadaveric donors, of which only four patients suffered from DGF.
One of the drawbacks when analysing renal biopsies is that these specimen are subject to sampling errors. In order to acquire a broader view of the staining, we assessed KIM-1 and NGAL staining derived from a rat IRI model. This model showed that the localization of the biopsy is of paramount importance and might explain why we could not find a significant correlation between the quantitative staining and fDGF, nor between quantitative tissue staining and the biomarker concentration in urine. Nevertheless, in a previous study, a significant correlation between KIM-1 tissue expression and urinary KIM-1 values was seen, independent of the underlying renal disorder [28] . It should be noted that this study used a semi-quantitative method to analyse the staining, which is more susceptible to both intra-and inter observer variability as compared with the method we used. Besides the sampling errors, the relatively small sample size, in particular of the patients without fDGF, might also have contributed to the fact that we did not find a significant association between quantitative tissue staining and fDGF and quantitative tissue staining and the biomarker concentration in urine.
Since the tubular compartment represents $80% of the renal mass, a marker that reflects functioning TECs seems obvious. One of the previously described methods to analyse this is by the TFS, calculated from standardized 99m Tc-MAG3 renography [20] . The TFS reflects the tubular extraction rate of 99m Tc-MAG3 via the organic anion transporter and has been shown to be an accurate method to analyse functioning PTECs and to monitor the evolution of DGF. It is, however, a timeconsuming method and also not suitable as a daily marker in the transplant clinic. In the current study, we investigated whether quantitative KIM-1 and NGAL staining were correlated with the TFS. We indeed found a significant inverse correlation between the TFS and quantitative KIM-1 staining, indicating that injury of the PTECs resulted in increased KIM-1 staining and in impaired uptake of 99m Tc-MAG3. Thus, quantitative KIM-1 staining may be additional value when determining the extent of injury. In contrast, there was no correlation between quantitative NGAL staining and the TFS. Interestingly, patients with a TFS 1.0 showed low quantitative NGAL staining, which appeared to be related to the presence of fibrosis. We hypothesized that this was inherent in the physiology of NGAL, since cortical NGAL staining is dependent on filtration and reabsorption by PTECs and this might be more or impaired longer in fibrotic kidneys.
In conclusion, KIM-1 and NGAL staining showed different localization and distribution in both rats and humans. Quantitative KIM-1 staining tended to be higher in patients with prolonged fDGF and was inversely correlated with the TFS. Based on the localization and physiology, NGAL might not be the ideal biomarker in the prediction of DGF, whereas KIM-1 has a greater potential. 
